Perspective Therapeutics, Inc. SEC filings CATX

Perspective Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Aug 16, 2006. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-Q Quarterly report Feb 9, 2022 Dec 31, 2021
10-Q Quarterly report Nov 10, 2021 Sep 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-Q Quarterly report Feb 9, 2021 Dec 31, 2020
10-Q Quarterly report Nov 13, 2020 Sep 30, 2020
10-Q Quarterly report May 13, 2020 Mar 31, 2020
10-Q Quarterly report Feb 12, 2020 Dec 31, 2019
10-Q Quarterly report Nov 13, 2019 Sep 30, 2019
10-Q Quarterly report May 10, 2019 Mar 31, 2019
10-Q Quarterly report Feb 13, 2019 Dec 31, 2018
10-Q Quarterly report Nov 9, 2018 Sep 30, 2018
10-Q Quarterly report May 4, 2018 Mar 31, 2018
10-Q Quarterly report Feb 9, 2018 Dec 31, 2017
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report May 10, 2017 Mar 31, 2017
10-Q Quarterly report Feb 9, 2017 Dec 31, 2016
10-Q Quarterly report Nov 9, 2016 Sep 30, 2016
10-Q Quarterly report May 10, 2016 Mar 31, 2016
10-Q Quarterly report Feb 9, 2016 Dec 31, 2015
10-Q Quarterly report Nov 9, 2015 Sep 30, 2015
10-Q Quarterly report May 15, 2015 Mar 31, 2015
10-Q Quarterly report Feb 17, 2015 Dec 31, 2014
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-Q Quarterly report Feb 14, 2014 Dec 31, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
10-Q Quarterly report May 15, 2013 Mar 31, 2013
10-Q Quarterly report Feb 14, 2013 Dec 31, 2012
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q Quarterly report May 15, 2012 Mar 31, 2012
10-Q Quarterly report Feb 14, 2012 Dec 31, 2011
10-Q/A Amended quarterly report Dec 13, 2011 Sep 30, 2011
10-Q Quarterly report Nov 14, 2011 Sep 30, 2011
10-Q Quarterly report May 16, 2011 Mar 31, 2011
10-Q Quarterly report Feb 14, 2011 Dec 31, 2010
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
10-Q Quarterly report May 12, 2010 Mar 31, 2010
10-Q/A Amended quarterly report Mar 25, 2010 Sep 30, 2009
10-Q Quarterly report Feb 16, 2010 Dec 31, 2009
10-Q Quarterly report Nov 16, 2009 Sep 30, 2009
10-Q Quarterly report May 15, 2009 Mar 31, 2009
10-Q Quarterly report Feb 17, 2009 Dec 31, 2008
10-Q Quarterly report Nov 14, 2008 Sep 30, 2008
10-Q Quarterly report May 13, 2008 Mar 31, 2008
10-Q Quarterly report Feb 11, 2008 Dec 31, 2007
10-Q Quarterly report Nov 9, 2007 Sep 30, 2007

Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CATX (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
728387
Former names
IsoRay, Inc. (until Feb 16, 2023); Isoray, Inc. (until Feb 16, 2023); CENTURY PARK PICTURES CORP (until Aug 3, 2005)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.